Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001926 · ClinicalTrials.gov registry record
The Connection Between Areas in the Brain of Blind Patients
A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 45
- Enrollment target
NCT00001926: Completed study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00001926 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001926 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to test the belief that specific areas of the brain are connected differently in blind patients than patients with sight. In addition, the study will examine the different anatomical connections between brain areas of patients who became blind early in life versus patients who became blind later.
Interventions
- DRUG O15
- DEVICE Cadwell rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 1999-04 |
| Est. Completion | 2003-11 |
What the finished NCT00001926 record still lists
NCT00001926 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which O15 is the first listed.
NCT00001926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001926 about?
NCT00001926 is a clinical study titled "The Connection Between Areas in the Brain of Blind Patients". The purpose of this study is to test the belief that specific areas of the brain are connected differently in blind patients than patients with sight. In addition, the study will examine the different anatomical connections between brain areas of patients who became blind early in life versus patien...
What is the current status of trial NCT00001926?
This trial is currently completed. The enrollment target is 45 participants. The study started on 1999-04. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00001926?
The interventions under investigation include: O15 (DRUG), Cadwell rTMS (DEVICE).
Who is sponsoring clinical trial NCT00001926?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia